Literature DB >> 23795757

The effect of personality disorders on treatment outcomes in patients with obsessive-compulsive disorders.

Nicola Thiel, Elisabeth Hertenstein, Christoph Nissen, Nirmal Herbst, Anne Katrin Külz, Ulrich Voderholzer.   

Abstract

The effect of comorbid personality disorders (PD) on treatment outcomes in obsessive-compulsive disorder (OCD) is unclear. The authors systematically review results from investigations of therapy outcomes in adult patients with OCD and a comorbid PD. PsycINFO and MEDLINE were searched for original articles. Twenty-three studies assessing PDs through interviews were selected. Cluster A PDs, particularly schizotypal PD, narcissistic PD, and the presence of two or more comorbid PDs, were associated with poorer treatment outcomes in patients with OCD. With regard to other PDs and clusters, the results are inconsistent or the sample sizes are too small to reach a conclusion. OCD patients with different comorbid PDs differ in their therapeutic response to treatment. To optimize the treatment of OCD, the predictive value of PDs on the treatment outcome should be further investigated, and treatment of Axis I and II comorbidity requires more attention.

Entities:  

Mesh:

Year:  2013        PMID: 23795757     DOI: 10.1521/pedi_2013_27_104

Source DB:  PubMed          Journal:  J Pers Disord        ISSN: 0885-579X


  8 in total

1.  General personality dimensions, impairment and treatment response in obsessive-compulsive disorder.

Authors:  Jack Samuels; O Joseph Bienvenu; Janice Krasnow; Ying Wang; Marco A Grados; Bernadette Cullen; Fernando S Goes; Brion Maher; Benjamin D Greenberg; Nicole C Mclaughlin; Steven A Rasmussen; Abby J Fyer; James A Knowles; James T Mccracken; John Piacentini; Dan Geller; S Evelyn Stewart; Dennis L Murphy; Yin-Yao Shugart; Mark A Riddle; Gerald Nestadt
Journal:  Personal Ment Health       Date:  2019-12-20

2.  Comorbid Personality Disorders in Obsessive-Compulsive Disorder and Its Symptom Dimensions.

Authors:  Francesco Bulli; Gabriele Melli; Veronica Cavalletti; Eleonora Stopani; Claudia Carraresi
Journal:  Psychiatr Q       Date:  2016-06

3.  Specialty knowledge and competency standards for pharmacotherapy for adult obsessive-compulsive disorder.

Authors:  Christopher Pittenger; Brian P Brennan; Lorrin Koran; Carol A Mathews; Gerald Nestadt; Michele Pato; Katharine A Phillips; Carolyn I Rodriguez; H Blair Simpson; Petros Skapinakis; Dan J Stein; Eric A Storch
Journal:  Psychiatry Res       Date:  2021-03-04       Impact factor: 11.225

4.  Coping strategies, hope, and treatment efficacy in pharmacoresistant inpatients with neurotic spectrum disorders.

Authors:  Marie Ociskova; Jan Prasko; Dana Kamaradova; Ales Grambal; Petra Kasalova; Zuzana Sigmundova; Klara Latalova; Kristyna Vrbova
Journal:  Neuropsychiatr Dis Treat       Date:  2015-05-15       Impact factor: 2.570

5.  The prediction of treatment outcomes by early maladaptive schemas and schema modes in obsessive-compulsive disorder.

Authors:  Nicola Thiel; Brunna Tuschen-Caffier; Nirmal Herbst; Anne Katrin Külz; Christoph Nissen; Elisabeth Hertenstein; Ellen Gross; Ulrich Voderholzer
Journal:  BMC Psychiatry       Date:  2014-12-25       Impact factor: 3.630

6.  Personality, Psychopathology, and Psychotherapy: A Pre-specified Analysis Protocol for Confirmatory Research on Personality-Psychopathology Associations in Psychotherapy Outpatients.

Authors:  Michael P Hengartner; Misa Yamanaka-Altenstein
Journal:  Front Psychiatry       Date:  2017-02-01       Impact factor: 4.157

7.  Psychological factors and treatment effectiveness in resistant anxiety disorders in highly comorbid inpatients.

Authors:  Marie Ociskova; Jan Prasko; Klara Latalova; Dana Kamaradova; Ales Grambal
Journal:  Neuropsychiatr Dis Treat       Date:  2016-06-24       Impact factor: 2.570

8.  Impact of personality status on the outcomes and cost of cognitive-behavioural therapy for health anxiety.

Authors:  Rahil Sanatinia; Duolao Wang; Peter Tyrer; Helen Tyrer; Mike Crawford; Sylvia Cooper; Gemma Loebenberg; Barbara Barrett
Journal:  Br J Psychiatry       Date:  2016-07-21       Impact factor: 9.319

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.